<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H7A6C2D9715114090AFEA991AC0DBCE31" public-private="public" bill-type="olc"> 
<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>114 HR 1186 IH: SALTS Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2015-02-27</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code> 
<congress>114th CONGRESS</congress>
<session>1st Session</session>
<legis-num>H. R. 1186</legis-num> 
<current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber> 
<action> 
<action-date date="20150227">February 27, 2015</action-date> 
<action-desc><sponsor name-id="T000238">Mr. Thornberry</sponsor> introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name>, and in addition to the Committee on the <committee-name committee-id="HJU00">Judiciary</committee-name>, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned</action-desc>
</action> 
<legis-type>A BILL</legis-type> 
<official-title>To amend the Controlled Substances Act relating to controlled substance analogues.</official-title> 
</form> 
<legis-body id="H442A74F09C5044F3AA00D2A783C5CC6F" style="OLC"> 
<section id="HD04822124F4D4283834BF789BC2CFB96" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Synthetic Abuse and Labeling of Toxic Substances Act of 2015</short-title></quote> or the <quote>SALTS Act</quote>.</text></section> <section id="H99F3E366F2824A7A89F8AC6747876563" section-type="subsequent-section"><enum>2.</enum><header>Controlled substance analogues</header><text display-inline="no-display-inline">Section 203 of the Controlled Substances Act (<external-xref legal-doc="usc" parsable-cite="usc/21/813">21 U.S.C. 813</external-xref>) is amended—</text> 
<paragraph id="HEC4D483760D3467E8B6965EA90DAA2A8"><enum>(1)</enum><text>by striking <quote>A controlled</quote> and inserting <quote>(a) <header-in-text level="subsection" style="OLC">In general</header-in-text>.—A controlled</quote>; and</text></paragraph> <paragraph id="HD71B19CA741845EA8491B93297960093"><enum>(2)</enum><text>by adding at the end the following:</text> 
<quoted-block display-inline="no-display-inline" id="HCEEA7B79290242D7B303C5E9257E6B97" style="OLC"> 
<subsection id="H2FB36BF097264B29BBF2DBC0373E77B2"><enum>(b)</enum><header>Determination</header><text>In determining whether a controlled substance analogue was intended for human consumption under subsection (a), the following factors may be considered, along with any other relevant factors:</text> <paragraph id="HCD6DB1C83DE543B8A87F627FDF1FDFFE"><enum>(1)</enum><text>The marketing, advertising, and labeling of the substance.</text></paragraph> 
<paragraph id="H919E7ABB6548496F95C48950E0A69F8F"><enum>(2)</enum><text>The known efficacy or usefulness of the substance for the marketed, advertised or labeled purpose.</text></paragraph> <paragraph id="H5C4459035BAA4E888824270FFE418E22"><enum>(3)</enum><text>The difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold.</text></paragraph> 
<paragraph id="HD7F8647F63CE499E8BED0023E1C435DE"><enum>(4)</enum><text>The diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance.</text></paragraph> <paragraph id="HA93DDDD3BD524D86B72678122C73CA2A"><enum>(5)</enum><text>Whether the defendant knew or should have known the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.</text></paragraph> 
<paragraph id="HD8CF89AFDD234983B16DEA3347B78D89"><enum>(6)</enum><text display-inline="yes-display-inline">Any controlled substance analogue that is manufactured, formulated, sold, distributed, or marketed with the intent to avoid the provisions of existing drug laws.</text></paragraph></subsection> <subsection commented="no" display-inline="no-display-inline" id="HF80D304BC222411AA88B3F659FA5699C"><enum>(c)</enum><header>Limitation</header><text>For purposes of this section, evidence that a substance was not marketed, advertised, or labeled for human consumption, by itself, shall not be sufficient to establish that the substance was not intended for human consumption.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></section> 
</legis-body> 
</bill> 


